default author photo

Nicolas Paleiron

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

22

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A multicenter phase 2 study evaluating Denosumab in combination with Nivolumab as second-line therapy for patients with stage IV non-small–cell lung cancer with bone metastases, DENIVOS-GFPC 06-2017

Number of pages: 21 Posted: 28 Apr 2026
Chantal Decroisette, Isabelle Monnet, Tristan Delory, Charles Ricordel, Axelle Demaegdt, Nicolas Paleiron, Lionel Falchero, Margaux Geier, gregoire Justeau, Marie Bernadi, Virgile Gazaille, Roland Schott, Sabine Vieillot, Pierre-Alexandre Hauss, Sophie Bayle, Melissa Petrier, Florian Guisier, Christos Chouaïd and Laurent Greillier
Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Centre Hospitalier Intercommunal de Créteil, Centre Hospitalier Pierre Bénite - Clinical Research Unit, CHU Rennes, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, CHU de Brest, University of Angers - CHU Angers, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Centre Hospitalier de Perpignan, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Normandie Université, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 22 (1,424,331)

Abstract:

Loading...

non-small cell lung cancer, Bone metastasis, immune checkpoint inhibitor, anti-resorptive agent, skeletal-related events